Biotage AB (publ) (STO: BIOT)
Sweden
· Delayed Price · Currency is SEK
148.90
+1.20 (0.81%)
Nov 21, 2024, 3:33 PM CET
Biotage AB Revenue
Biotage AB had revenue of 490.00M SEK in the quarter ending September 30, 2024, with 9.13% growth. This brings the company's revenue in the last twelve months to 2.12B, up 32.06% year-over-year. In the year 2023, Biotage AB had annual revenue of 1.86B with 18.90% growth.
Revenue (ttm)
2.12B
Revenue Growth
+32.06%
P/S Ratio
5.58
Revenue / Employee
3.14M
Employees
674
Market Cap
11.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
Dec 31, 2019 | 1.10B | 190.48M | 20.91% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 519.35B |
Swedish Orphan Biovitrum AB (publ) | 25.44B |
Sectra AB (publ) | 3.17B |
Getinge AB (publ) | 33.59B |
Camurus AB (publ) | 1.69B |
Vitrolife AB (publ) | 3.56B |
Medicover AB (publ) | 22.60B |
Elekta AB (publ) | 18.12B |